跳至主要内容
临床试验/CTRI/2022/10/046402
CTRI/2022/10/046402
招募中
未知

A Retrospective, Observational Study to Determine Safety and performance of Neohexa-Sirolimus-Eluting Coronary Stent System (SES) in all-comer patients with coronary artery disease (CAD).

Sahajanand Laser Technology Ltd0 个研究点目标入组 0 人待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
Sahajanand Laser Technology Ltd
状态
招募中
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Observational

研究者

发起方
Sahajanand Laser Technology Ltd

入排标准

入选标准

  • 1\. Males and Females more than 18 years of age.
  • 2\. Subjects who had signed the Hospital Consent Form.
  • 3\. The subjects who have been treated with PCI and implanted with Neohexa Drug\-Eluting Stent as a part of their treatment of Coronary Artery Disease without any further indication for emergent coronary artery bypass graft surgery
  • 4\. Patients who have completed a minimum of 24 months after device implantation (device implanted between 01\-01\-2017 to 31\-12\-2019\)

排除标准

  • 1\. Subjects who are treated with stents other than Neohexa stent in the same vessel.
  • 2\. Subjects implanted with Neohexa stent after 31\-12\-2019

结局指标

主要结局

未指定

相似试验